SEPTInvestingStart Free

LAB 424B3: Acquisition

Standard BioTools

Filed with the SEC on · accession 0001140361-26-041305

LAB filed a 424B3 (prospectus (offering)) with the SEC on Oct 30, 2026. Standard BioTools filed a 424B3 resale prospectus covering up to 1,551,769,528 shares of common stock issued to selling securityholders of Treeline Biosciences in connection with the merger of a Standard BioTools subsidiary into Treeline, with Treeline surviving as a wholly owned subsidiary. The stock moved -1.6% by the first close after the filing.

Summary of the filing

Standard BioTools filed a 424B3 resale prospectus covering up to 1,551,769,528 shares of common stock issued to selling securityholders of Treeline Biosciences in connection with the merger of a Standard BioTools subsidiary into Treeline, with Treeline surviving as a wholly owned subsidiary. The merger is accounted for as a reverse recapitalization with Treeline as the accounting acquirer, and the combined company will be renamed Treeline Biosciences, Inc. and trade under the symbol TRLN.

For details, click here →How to read a 424B3 →

Key details

Maximum number of shares of Standard BioTools common stock registered for resale by Selling Securityholders$1.6B
Estimated Exchange Ratio (high point of range) used to determine shares issued in the merger$12
Registrant/acquirerStandard BioTools Inc.
Merger target/accounting acquirerTreeline Biosciences, Inc.
Merger subsidiary of standard biotoolsSiri Merger Sub, Inc.

How LAB stock reacted

Close before

$0.62

Oct 29, 2026

First close after

-1.61%

$0.61

5 trading days

+0.39%

$0.62

Since filing

+2.58%

$0.64

✦ Ask GOAX AI about this filing — what it means for LAB, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LAB?

Click here

Frequently asked questions

What did LAB file with the SEC on Oct 30, 2026?

LAB filed a 424B3 (Acquisition). Standard BioTools filed a 424B3 resale prospectus covering up to 1,551,769,528 shares of common stock issued to selling securityholders of Treeline Biosciences in connection with the merger of a Standard BioTools subsidiary into Treeline, with Treeline surviving as a wholly owned subsidiary. The merger is accounted for as a reverse recapitalization with Treeline as the accounting acquirer, and the combined company will be renamed Treeline Biosciences, Inc. and trade under the symbol TRLN.

What does a acquisition mean for LAB stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did LAB stock react to this filing?

LAB closed at $0.62 before the filing and $0.61 on Oct 30, 2026 (-1.61%). Five trading days later: $0.62 (+0.39%).

Other LAB SEC filings

Get alerts when LAB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
LAB overviewLAB analysisLAB newsLatest SEC filings